Close

Form 8-K SOLIGENIX, INC. For: Sep 23

September 24, 2021 4:02 PM EDT
0000812796falseDENASDAQNASDAQ0000812796us-gaap:WarrantMember2021-09-232021-09-230000812796us-gaap:CommonStockMember2021-09-232021-09-2300008127962021-09-232021-09-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):  September 23, 2021

 

Commission File No. 000-16929

 

Soligenix, Inc.

(Exact name of small business issuer as specified in its charter)

 

DELAWARE

 

41-1505029

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

 

 

29 Emmons Drive,

Suite B-10

Princeton, NJ

 

08540

(Address of principal executive offices)

 

(Zip Code)

(609) 538-8200

(Issuer’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $.001 per share

 

SNGX

 

The Nasdaq Capital Market

Common Stock Purchase Warrants

 

SNGXW

 

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On September 23, 2021, Soligenix, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders, at which the following items were voted upon:

 

(1)

Election of Directors:

 

The following five nominees were elected as directors to serve until the 2022 Annual Meeting of Stockholders by votes as follows:

 

Name

 

For

 

 

Withheld

 

Gregg A. Lapointe, CPA, MBA

 

 

5,811,379

 

 

 

1,004,560

 

Diane L. Parks, MBA

5,874,514

941,425

Robert J. Rubin, MD

 

 

5,355,997

 

 

 

1,459,942

 

Christopher J. Schaber, PhD

 

 

5,705,134

 

 

 

1,110,805

 

Jerome B. Zeldis, MD, PhD

 

 

5,321,119

 

 

 

1,494,820

 

 

There were 13,495,186 broker non-votes in the election of directors.

 

(2)

Non-binding advisory vote on executive compensation:

 

The proposal to approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the Company’s 2021 proxy statement was approved, and the votes were as follows:

 

For

 

Against

 

Abstain

5,342,852

 

942,224

 

530,863

 

There were 13,495,186 broker non-votes on this proposal.

(3)

Ratification of the Appointment of Independent Registered Public Accounting Firm:

 

The proposal to ratify the appointment of EisnerAmper, LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2021 was approved by votes as follows:

 

For

 

Against

 

Abstain

19,836,966

 

273,078

 

201,081

 

There were no broker non-votes on this proposal.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Soligenix, Inc. 

September 24, 2021 

By:

/s/ Christopher J. Schaber 

 

 

Christopher J. Schaber, Ph.D.

President and Chief Executive Officer

(Principal Executive Officer)

3



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings